Counterfeit, Falsified, Substandard: Words That Mean Different Risks

Counterfeit, falsified, substandard, adulterated, diverted and unlicensed describe different problems with a medicine, and the differences are practical rather than pedantic. One is about lying about identity, one is about failing to meet a manufacturing standard, one is about a legitimate product leaving the legitimate chain, and one is about a real product not being authorised where you are. They imply different risks, different responsible parties, and different places to report.

Sellers and headlines blur them together, which makes it harder to work out what actually happened when something goes wrong.

Counterfeit and falsified: lying about what it is

Both terms cover a product that misrepresents its identity, source, or composition. In practice this means a product presenting itself as a particular medicine from a particular manufacturer when it is not. Terminology differs by jurisdiction — some frameworks prefer falsified because counterfeit also carries a trademark meaning, and the trademark question is legally distinct from the public-health one.

The risk profile is the one described in why counterfeit medication is dangerous even when it looks right: contents unknown, quantity uncontrolled, and no recall route. This is the category where the danger is unbounded, because there is no specification the product was ever supposed to meet.

Substandard: the right product, made badly

A substandard medicine is a genuine product from a real manufacturer that fails to meet its own specification. It may have degraded, been stored outside its temperature range, been produced in a batch with a manufacturing fault, or be past its expiry.

The important structural difference is that a real, identifiable manufacturer exists and is accountable, and there is a specification the product should have met. That is why substandard problems get caught: batches are testable, records exist, and recalls are possible. This category is also the reason expiry dates and storage instructions are not bureaucratic — a genuine medicine stored badly can become a substandard one.

Adulterated and contaminated: something added or introduced

Adulteration is the deliberate addition of something that should not be present; contamination is usually accidental. In counterfeit production both are common, because there is no clean-room discipline and no incentive to avoid cheap fillers. In legitimate production, contamination is the sort of thing that triggers a recall.

Worth knowing because the terms appear in recall notices, and a recall for a contamination issue in a genuine product is a very different event from a counterfeit seizure, even though both may be reported with alarming language.

Diverted: real medicine, wrong route

Diversion is a genuine product that left the legitimate supply chain and came back into circulation. Stock stolen in transit, product intended for one market or programme resold elsewhere, or medicine obtained on prescription and sold on. The product itself may be exactly what it claims to be.

The risk here is subtler. Storage conditions during the detour are unknown, the product may be near or past expiry, and repackaging may have occurred. And because the medicine is real, it is much harder to detect than a counterfeit — while the person selling it is by definition operating outside the law, so nothing else they claim is reliable either.

Unlicensed and unauthorised: real medicine, not approved here

A medicine can be genuine, correctly made, and still not authorised for sale in your country. Approvals are jurisdictional, and a product legitimately marketed in one country may have no authorisation in another — or may be authorised under a different name, formulation, or set of conditions.

This category is where sellers do the most rhetorical work, because “authorised in Europe” or “approved in India” sounds like an approval while saying nothing about your jurisdiction. What your country’s rules are, and whether any exception applies to you, is not something this site will state as fact; the relevant point is that a seller’s assertion about your law is a sales claim, as discussed in when a seller tells you cross-border buying is legal for you.

Why the distinctions change what you do

Different categories mean different reporting routes and different urgency. A suspected counterfeit is a matter for a medicines regulator and possibly law enforcement, and the product should be kept. A suspected substandard or contaminated genuine product is a matter for the pharmacy, the manufacturer, and the regulator’s reporting system, and the batch number is the key detail. A suspected diversion concerns the seller more than the product. An unlicensed import is primarily a regulatory question about the seller’s operation.

Practical routes are covered in where a suspicious online pharmacy should be reported.

How to use the vocabulary without over-claiming

You are usually not in a position to know which category applies, and you do not have to be. Describing what you observed — where it came from, what arrived, what the packaging said, what happened — is more useful to a pharmacist or regulator than picking a label. Guessing “counterfeit” when the real issue was storage can send an inquiry in the wrong direction.

The value of knowing the terms is in reading: it lets you interpret recall notices, regulator warnings, and news coverage accurately, and it stops a seller’s careful phrasing about approvals in other countries from doing work it has not earned.

Where to take an actual concern

A pharmacist is the right first stop for a specific product, and a prescriber for anything about your health. They can identify what was dispensed, read the batch details, and tell you whether what you have describes a manufacturing issue, a substitution, or something that needs escalating. Nothing on this page substitutes for that conversation.